Distinct inflammatory imprint in non-cirrhotic and cirrhotic patients before and after direct-acting antiviral therapy

Background/Aims Hepatitis C virus (HCV) infection remains a global health challenge, leading to chronic liver disease, cirrhosis, and hepatocellular carcinoma (HCC). Despite the high efficacy of direct-acting antiviral therapy in achieving sustained virologic response (SVR), concerns persist regardi...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Moana Witte, Carlos Oltmanns, Jan Tauwaldt, Hagen Schmaus, Jasmin Mischke, Gordon Grabert, Mara Bretthauer, Lennart M. Roesner, Thomas Werfel, Katja Deterding, Benjamin Maasoumy, Heiner Wedemeyer, Tim Kacprowski, Anke R.M. Kraft, Markus Cornberg
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Korean Association for the Study of the Liver 2025-10-01
Sarja:	Clinical and Molecular Hepatology
Aiheet:	hepatitis c virus direct-acting antiviral therapy cirrhosis soluble inflammatory marker hepatocellular carcinoma
Linkit:	http://e-cmh.org/upload/pdf/cmh-2025-0292.pdf
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!